Actelion Reports $716 Million Global Sales Of Tracleer In First Nine Months Of 2007
Swiss company is cagey on the impact of Gilead’s PAH product Letairis on sales of Tracleer during its third quarter 2007 earnings call.
Swiss company is cagey on the impact of Gilead’s PAH product Letairis on sales of Tracleer during its third quarter 2007 earnings call.